If youre interested in GLP-1 weight loss treatments, Pure Med Spa Chicago is here to help

These benefits have been demonstrated in large, well-designed cardiovascular outcome trials, including: Liraglutide (Victoza) the LEADER trial , which showed a significant reduction in cardiovascular death and all-cause mortality Semaglutide (Ozempic) the SUSTAIN-6 trial , demonstrating fewer major adverse cardiovascular events, particularly stroke Dulaglutide (Trulicity) the REWIND trial , which showed a significant reduction in major cardiovascular events even in people without established cardiovascular disease Tirzepatide (Mounjaro) cardiovascular outcome data from the SURPASS-CVOT programme are emerging, with early results suggesting cardiovascular benefit compared with insulin therapy These cardiovascular effects are a key reason why GLP-1based therapies are now recommended earlier in the treatment pathway for people with type 2 diabetes who have established heart disease or are at high cardiovascular risk

For example, the LEADER trial showed positive renal effects with the use of liraglutide primarily by the reduction of macroalbuminuria
Learn More
This guide covers everything you need to know about taking your GLP-1 injection early
Further studies are required to clarify the complex interactions between GLP-1 RAs and various neuropsychiatric processes